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Abstract 
The interaction between glutathione S‐transferase and its antibody α‐glutathione S‐transferase (B‐14) was 
studied using fluorescence anisotropy, subsequent to glutathione S‐transferase bioconjugation with 
fluorescein‐5‐maleimide, leading to the determination of the dissociation and association binding 
constants, Kd and Ka; good binding specificity was observed between glutathione S‐transferase and the 
antibody B‐14. The use of spectroscopic techniques, fluorescence anisotropy in particular, is a useful and 
favourable tool to study biochemical problems. 
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1. Introduction 
Glutathione S‐transferases (GSTs) [1] constitute a family of detoxification enzymes that are involved in the 
metabolism of endogenous and xenobiotic compounds [2], [3], [4] and [5]. All of these enzymes catalyze 
the conjugation of glutathione to the electrophilic center of a variety of substrates, resulting in a more 
water soluble product that can be further degraded or transported out of the cell. GSTs have been 
implicated in the development of anticancer drug resistance and have been found in elevated levels in 
tumors [6]. 
The Glutathione S‐transferase Gene Fusion System is a versatile system for the expression, purification and 
detection of fusion proteins produced in Escherichia coli. The system is based on inducible, high‐level 
expression of genes or gene fragments as fusions with Schistosoma japonicum GST [7]. Expression in E. coli 
yields fusion proteins with the GST moiety at the amino terminus and the protein of interest at the carboxyl 
terminus. The protein accumulates within the cell's cytoplasm. 
The GST Gene Fusion System has been used successfully in many applications including molecular 
immunology [8], the production of vaccines [9] and [10] and studies involving protein–protein [11] and 
protein–DNA [12] interactions. 
Interactions between antigen and antibody involve non‐covalent binding of an antigenic determinant to the 
variable region of both the heavy and light immunoglobulin chains. These interactions are analogous to 
those observed in enzyme–substrate interactions and they can be defined similarly. To describe the 
strength of the antigen (Ag) antibody (Ab) interaction, one can define the affinity constant (K) as shown by 
equation (1):  
equation(1) 
K=[Ab−Ag][Ab]×[Ag]=104 to 1012M−1 
Therefore, the greater the K, the stronger the affinity between antigen and antibody. These interactions are 
the result of complementarity in shapes, hydrophobic interactions, hydrogen bonds and Van der Waals 
forces. 
Anisotropy measurements [13] are based on the molecular motion of fluorescent molecules in solution in 
the time window occurring between absorption and emission of light. According to equation (2), the 
fluorescence anisotropy (r) values were determined as:  
equation(2) 
  
where Ivv and Ivh represent the vertically and horizontally polarized emission intensities, respectively, 
following instrumental excitation with vertically polarized light and G is a correction factor which detects 
the instrumental sensitivity of the polarization direction of emission. G is defined as G = Ihv/Ihh, where Ihv 
and Ihh represent the vertically and horizontally polarized emission intensities obtained by excitation with 
horizontally polarized light.  
Molecules in solution rotate and tumble. In the case of small molecules, the movement is very rapid, but 
the movement of larger molecules becomes slower. When fluorescent‐labelled small molecules in solution 
are excited with a plane polarized light (Fig.1, top), the emitted light is depolarized due to fast movement of 
the molecule. However, when the fast‐moving small fluorescent‐labelled molecule is bound to the receptor 
having a large molecular mass, the movement of the conjugate is restricted and becomes slow. When such 
a conjugate is irradiated with a polarized light, the emitted light remains obviously polarized (Fig.1, 
bottom). 
 Fig. 1. 
Principle of the assay of binding reaction using fluorescence anisotropy. 
A binding isotherm can be easily constructed by titrating a fixed concentration of fluorescent‐tagged 
molecules (GST labelled with fluorescein‐5‐maleimide in this case) with a binding protein (the antibody in 
this case). From such data, Kd and Ka can be obtained by non‐linear regression analysis. In a typical 
procedure, the concentration of the fluorescent‐labelled ligand is kept constant, and fluorescence 
anisotropy is measured by changing the concentrations of the receptor solution. The anisotropy value at 
each concentration is measured and used to generate a binding isotherm. 
There are many applications using fluorescence anisotropy in DNA–protein and DNA–DNA interactions [14], 
protein–protein interactions [15], protease assays [16], immunoassays [17], conformational changes of 
proteins [18], and cell‐biochemical studies [19]. 
The molecular basis of the specificity of antigen–antibody interactions is still poorly understood and very 
few data are available in the literature referring to protein–antibody interaction studied by surface plasmon 
resonance [20], fluorescence correlation spectroscopy (FCS) [21] and [22] and surface‐enhanced Raman 
spectroscopy (SERS) [23]. This is due partly to the difficulty of analyzing in detail the nature of the 
molecular contacts. In their study, Altschuh et al. [20] worked on the determination of kinetic constants for 
the interaction between a monoclonal antibody and some peptides. They described a functional analysis of 
the interaction between a monoclonal antibody raised against tobacco mosaic virus (TMV) protein and a 
peptide corresponding to residues 134–146 of this protein. Differences in binding affinity resulting from 
single substitutions in the peptide were measured using the biosensor technology. They provided evidence 
of association constants in the order of 2.6–3.7 × 107 M−1 depending on the different peptide involved. 
Another paper [24] reported the kinetic analysis of monoclonal antibody–antigen interactions providing a 
Ka which varies around 3.7 × 107 M−1 and 1.5 × 108 M−1. Li et al. [25] utilized affinity capillary 
electrophoresis (ACE), a form of capillary zone electrophoresis (CZE) to determine the binding constant (Ka) 
of specific antibodies against bovine serum albumin (BSA) and the healthy prion protein (PrPc), in buffer 
solutions at fixed pHs, approximating to in vivo conditions. They derived Ka values as being 1.8 × 107 M−1 
for the Rubenstein antibody and 1.9 × 107 M−1 for the VMRD antibody. 
In the present work, the interaction between GST protein and its antibody was analysed for the first time. 
GST protein has been bioconjugated with a fluorophore, i.e. fluorescein‐5‐maleimide (Scheme 1) and its 
interaction with its antibody α‐GST (B‐14) was studied by fluorescence anisotropy. The dissociation and 
association binding constants (Kd and Ka) have been determined by non‐linear regression analysis. 
 
Scheme 1. 
Synthesis of fluorescein‐5‐maleimide. 
 
2. Experimental section 
2.1. Materials 
GST was produced in E. coli BL21 cells using pGEX vector systems. Bacteria were sonicated in buffer A1 (50 
mM TrisHCl pH 7.5, 1% TritonX100, 150 mM NaCl, 5 mM MgCl2, 1 mM DTT) containing protease inhibitors. 
Lysates were incubated with glutathione‐coupled Sepharose 4B beads (GE Healthcare Life Sciences) for 1 h 
at 4 °C. After washing, the bounded beads were incubated with 2 ml of buffer B1 (50 mM TrisHCl pH 8.0, 
100 mM NaCl, 2 mM DTT, 20 mM glutathione) overnight to perform affinity‐chromatography separation. 
The eluates were dialyzed against PBS using Slide‐A‐Lyzer 3.5K (PIERCE). Recombinant protein 
concentrations were determined by Comassie‐stained gels. 
α‐GST (B‐14) is a mouse monoclonal antibody raised against the 26 kDa GST specific domain of a fusion 
protein encoded by a pGEX.3X recombinant vector. It is recommended for detection of glutathione‐S‐
transferase of S. japonicum origin and GST fusion proteins. It was purchased from Santa Cruz Biotechnology 
Inc. and used as received. 
2.2. Experimental techniques 
Fluorescence anisotropy measurements were recorded using an LS55 Perkin Elmer spectrofluorimeter 
equipped with a xenon lamp source, a 5 mm path length quartz cell, Polaroid filters and a thermostatted 
bath kept at 25 °C. Samples were excited at 494 nm and monitored at 515 nm. Slit widths were 2.5/15 nm 
and integration time was 10 s. G factor was estimated every day before starting measurements. 
UV–Vis measurements were recorded using a Shimadzu UV‐1700 Pharma Spec Spectrophotometer 
equipped with 1.0 cm path length quartz cells. 
1H NMR spectra were performed on a Jeol EX400 instrument in DMSO‐d6 solution using the DMSO signal 
as a reference. NMR signals are described by use of s for singlet, d for doublet, t for triplet, m for multiplet. 
Mass spectra were collected by a Finnigan Mat TSQ700 Spectrometer. ESI–MS spectra were recorded using 
an LCQ Deca XP plus spectrometer (Thermo, Rodano, Italy), with electrospray interface and ion trap as 
mass analyzer. The flow injection effluent was delivered into the ion source using nitrogen as sheath and 
auxiliary gas. 
2.3. Fluorescein‐5‐maleimide synthesis 
Fluorescein‐5‐maleimide was synthesised as reported by Reddy et al. [26]. 
2.3.1. Synthesis of N‐(5‐fluoresceinyl)maleamic acid 
To a stirred solution of amine I (2.88 mmol) in AcOH (300 ml) maleic anhydride II (2.88 mmol) was added 
and the resulting solution was stirred at r.t. for 4 h. Precipitated amic acid III was filtered, washed with 
EtOAc (600 ml), dried and used as such without further purification. Yield: 74% (yellow solid), Mp: >300 
°C. 
2.3.2. Synthesis of N‐(5‐fluoresceinyl)maleimide 
HMDS (Hexamethyldisilazane) (1.37 g, 8.48 mmol) was added to a stirred suspension of amic acid III (0.95 g, 
2.12 mmol) and ZnCl2 (0.58 g, 4.24 mmol) in a mixture of benzene (115 ml) and DMF (13 ml) and the 
resulting mixture was refluxed for 2.5 h. After cooling to r.t., the mixture was filtered and filtrate was 
concentrated under vacuum. The residual DMF portion was poured into ice‐water (50 ml) and the aqueous 
phase was acidified to pH 4.0 by adding 0.1 N HCl. On cooling, fluorescein‐5‐maleimide IV (0.84 g) was 
obtained in 92.3% yield as an orange‐yellow solid, mp>300 °C [26]. 
1H NMR (DMSO‐d6): δ = 10.20 (s, 2H), 8.00 (d, J = 1.1 Hz, 1H), 7.80 (dd, J = 1.6, 8.2 Hz, 1H), 7.42 (d, J = 8.1 
Hz, 1H), 7.28 (s, 2H), 6.55–6.71 (m, 6H). 
MS (ESI): m/z (%) = 428 (M−1), 458 (M – 1, 33). 
2.4. Bioconjugation experiments 
GST protein has been bioconjugated with fluorescein‐5‐maleimide following the reported protocol [27]. 
The sulfhydryl‐containing protein GST was dissolved at a concentration of 1–10 mg/ml in 20 mM sodium 
phosphate, 0.15 M NaCl, pH 7.2. Fluorescein‐5‐maleimide was then dissolved in DMF at a concentration of 
10 mM protecting it from light and a 25‐fold molar excess of fluorescein‐5‐maleimide solution was added to 
the protein solution. After for 4 hours of reaction at room temperature in the dark the crude derivative was 
immediately purified using gel filtration on PD10 columns Sephadex® G‐25 (Amersham Bioscience) using a 
phosphate buffer saline solution (10 mM PBS, pH = 7.4) as eluent. The solutions were protected from light 
during the chromatography. 
2.5. GST–antibody interaction 
During observation of anisotropy, the temperature was kept constant because it greatly affects the 
molecular motion of the conjugate in the solution. Fluorescence anisotropy for each titration point was 
measured 5 times after a 3 min incubation at 20 °C. The final concentration includes a dilution factor to 
correct for the volume of added protein solution. 
The interactions were undertaken with a GST concentration of 1.00 × 10−8 M. GST (B‐14) antibody 
solutions at different concentrations were prepared by diluting a 2.50 × 10−6 M stock solution. 
After pre‐equilibration, the appropriate amount of protein stock solution was added and the fluorescence 
signal monitored until stable. The sample was then titrated with aliquots (5 μl) of antibody solution and 
the anisotropy values were collected. 
3. Results and discussions 
3.1. Dye/Protein ratio calculation 
The dye/protein ratios (D/P) of the conjugates were determined by the absorption spectra of the labelled 
proteins, registered in 10 mM PBS (pH = 7.4) according to the relationship reported in equation (3):  
equation(3) 
D/P=Amax·ɛprot(A280−cAmax)·ɛdye 
where A280 is the absorption of the conjugate at 280 nm; Amax is the absorption of the conjugate at the 
absorption maximum of the corresponding fluorescein‐5‐maleimide; c is a correction factor which must be 
used to adjust for amount of A280 contributed by the dye because fluorescent dyes also absorb at 280 nm 
and equals the A280 of the dye divided by the Amax of the dye (c = 0.29); ɛprotein (55310 cm−1 M−1) and ɛdye 
(63096 cm−1 M−1) are the molar absorption coefficients for the protein used and fluorescein‐5‐maleimide, 
respectively.  
The fluorescein‐5‐maleimide correction factor was calculated by UV–Vis experiments, the molar absorption 
coefficient of the free dye (ɛdye) was calculated from the slope of a Lambert–Beer plot while the molar 
absorption coefficient of the protein was estimated from knowledge of its amino acid composition [28]. 
From the molar absorption coefficient of tyrosine, tryptophan and cystine (cysteine does not absorb 
appreciably at wavelengths >260 nm, while cystine does) at a given wavelength, the molar absorption 
coefficient of the native protein in water can be computed using equation (4) [29].  
equation(4) 
ɛ=(nW×5500)+(nY×1490)+(nC×125)ɛ=(nW×5500)+(nY×1490)+(nC×125) 
where n is the number of each tryptophan (W), tyrosine (Y) and cystine (C) residue respectively and the 
stated values are the amino acid molar absorption coefficients at 280 nm.  
The bioconjugation was repeated several times and the resulting D/P ratio obtained was around 1 with 
values varying from 1.17 to 1.71. Moreover, we detected that different fractions coming from the same 
purification have different D/P ratios. This finding, in combination with the consideration that GST presents 
only 1 cysteine residue at the N‐terminal, suggests that the first fraction (which usually has a D/P closer to 
1) consists of the labelled protein alone (where the fluorophore is covalently labelled) while in the following 
fractions the non covalently labelled fluorophore is also present in solution (leading to higher D/P values). 
To avoid possible signal interferences, we selected the first fraction for the interaction studies. 
To validate the reliability of the proposed bioconjugation, we performed a different purification method 
found in literature and suitable for peptides [30] which consists in removing the non‐labelled fluorescein by 
precipitation with acetone. After fluorophore precipitation, we evaluated the D/P and the obtained value 
was 1, confirming that fluorescein‐5‐maleimide is covalently labelled to GST protein. Unfortunately, the use 
of acetone for the fluorophore precipitation caused protein denaturation as also reported in literature [30], 
therefore this bioconjugate was inappropriate for the binding studies, but able to confirm the validity of the 
gel filtration method. 
3.2. Data analysis and results 
The interaction between GST and α‐GST (B‐14) was studied by fluorescence anisotropy. The concentration 
of the fluorescent‐labelled ligand (GST conjugated with fluorescein‐5‐maleimide) is kept constant, and 
anisotropy is measured by changing the concentrations of the receptor (B‐14) solution. The anisotropy 
value at each concentration is measured and used to generate a binding isotherm. 
Results of a typical experiment are presented in Fig. 2. Data are plotted as the anisotropy of the complex as 
a function of added GST (B‐14). Binding isotherms were fitted to equation (5) by non‐linear regression 
(using the programs Origin 6.1, GraphPad Prism 4 and TableCurve 2D v5.01):  
equation(5) 
A=Af+(Ab−Af)[Ka[L]1+Ka[L]] 
where A is the experimentally measured anisotropy, Af is the anisotropy of free fluorescent molecules, Ab 
is the anisotropy of bound fluorescent molecules, Ka is the association binding constant and [L] is the ligand 
concentration (i.e. in this case α‐GST concentration) [31]. (A further explanation and the detailed 
derivation of equation (5) is reported in Supporting information)  
 
Fig. 2.   
Fitting curve of an example of GST – B‐14 interactions. 
As is evident from the reported graph (Fig. 2), an interaction between the GST protein and its antibody B‐14 
does occur. Actually, a variation of the anisotropy signal (an increase in particular in this case) by increasing 
the antibody concentration is visible. The anisotropy value increased because the fluorescent‐labelled 
protein GST, having reacted with the antibody, has decreased its rotational movement leading to a less 
depolarized emission light. 
By fitting the interaction curves for a series of experiments, the following mean results were obtained: Af = 
0.140 ± 0.03, Ab = 0.252 ± 0.06 and the evaluated association constant Ka was 8.27 × 108 M−1 ± 2.69 × 
107 while the dissociation constant Kd was 1.21 × 10−9 M. 
Since this interaction has never been analysed before, we are not able to compare the binding constants 
obtained for this specific protein–antibody interaction. In any case, the binding constants obtained are in 
agreement with the few data available in literature referring to other protein–antibody interaction. As 
already reported previously, Altschuh et al. [20] had worked on the determination of kinetic constants for 
the interaction between a monoclonal antibody and some peptides and provided evidence of association 
constants in the order of 2.6–3.7 × 107 M−1 depending upon the peptide involved. Karlsson et al. [24] 
reported the kinetic analysis of monoclonal antibody–antigen interactions providing a Ka which varies 
around 3.7 × 107 M−1 and 1.5 × 108 M−1. Li et al. [25] derived Ka values as being 1.8 × 107 M−1. The 
binding constants values obtained agree well with the data reported by these authors and are also in good 
agreement within the same set of interaction providing good repeatability and consistency. 
4. Conclusions 
The interaction between GST and its antibody α‐GST (B‐14) was studied by fluorescence anisotropy, after 
GST bioconjugation with fluorescein‐5‐maleimide, leading to the determination of the dissociation and 
association binding constants (Kd and Ka). By comparing the results obtained for GST‐B‐14 interaction with 
the data found in literature referring to protein–antibody interactions, we can assert that a good binding 
specificity is present between GST and the antibody B‐14 and that the use of fluorescence anisotropy is a 
useful and favourable tool to study biochemical problems. 
The use of fluorescence anisotropy has provided equilibrium determinations based on the observation of 
the molecular movement of the fluorescent molecules in solution. 
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